Michael B. Edmond, MD, MPH,medmond/Edmond _CV.pdfMichael B. Edmond, MD, MPH, MPA - 3 - •...

1

Curriculum Vitae

Michael B. Edmond, MD, MPH, MPA 1. PERSONAL INFORMATION:

1.1 Michael Bruce Edmond, MD, MPH, MPA 1.2 Home: 23 James Falls Drive, Richmond, VA, 23221; 804‐353‐3197 1.3 Office: Box 980019, Richmond, VA 23298‐0019; 804‐828‐2121 1.4 E‐mail: [email protected] 1.5 Webpage: http://www.people.vcu.edu/~medmond/ 1.6 Spouse: Laurie Lyckholm, MD

Division of Hematology, Oncology and Palliative Care, VCU Medical Center

2. LICENSURE/CERTIFICATION: 2.1 Virginia, #0101053269 2.2 Diplomate in Internal Medicine (#125791), September 1989 (certified indefinitely)

Diplomate in Infectious Diseases (#125791), certified November 1992, recertified November 2002

3. EDUCATION:

• Virginia Commonwealth University School of Government and Public Affairs, Master of Public Administration, Executive Leadership, 2003

• University of Pittsburgh Graduate School of Public Health, Master of Public Health, Infectious Diseases and Microbiology, 1991

• West Virginia University School of Medicine, M.D., 1986 • Fairmont State College, Fairmont, WV, B.S., summa cum laude, Biology, 1982

4. MILITARY SERVICE: None. 5. POSTDOCTORAL TRAINING:

• Fellowship, Hospital and Clinical Epidemiology, University of Iowa, 1992‐1994 • Fellowship, Infectious Diseases, University of Pittsburgh, 1990‐1992 • Internship and Residency, Internal Medicine, West Virginia University, 1986‐1989

6. ACADEMIC APPOINTMENTS:

• Chair, Division of Infectious Diseases, VCU, 2008— • Interim Chair, Division of Infectious Diseases, VCU, 2005‐2006 • Professor of Internal Medicine, Epidemiology and Community Health, VCU, 2004— • Interim Director, Internal Medicine Residency Program, 2004 • Associate Director, Preventive Medicine Residency Program, VCU, 2004‐2006 • Medical Director, Performance Improvement, VCU Health System, 2003‐2007 • Associate Professor of Preventive Medicine, VCU, 2002‐2004 • Interim Director, Preventive Medicine Residency Program, 2002‐2003 • Associate Professor of Internal Medicine, Divisions of Quality Health Care and Infectious

Diseases, VCU, 1998‐2004 • Associate Chair for Education, Department of Internal Medicine, VCU, 1998—

Michael B. Edmond, MD, MPH, MPA

- 2 -

• Attending Physician, Internal Medicine and Infectious Diseases, VCU Medical Center, April 1996‐present

• Assistant Professor of Internal Medicine, Divisions of Quality Health Care and Infectious Diseases, VCU, 1995‐1998

• Director, Internal Medicine Residency Program, VCU, 1995‐2001 • Hospital Epidemiologist, VCU Health System, 1995— • Director, Hospital Epidemiology Fellowship Program, VCU, 1995— • Interim Chair, Division of Quality Health Care, VCU, 1995‐1996 • Assistant Professor, Division of General Medicine, Clinical Epidemiology and Health Services

Research, University of Iowa, 1994‐1995 • Chief Medical Resident and Instructor of Internal Medicine, West Virginia University, 1989‐90

7. MEMBERSHIP – SCIENTIFIC, HONORARY AND PROFESSIONAL SOCIETIES

• American College of Physicians o Member, Governor’s Council, Virginia Chapter, 1998‐2001

• American Society for Microbiology • American College of Physician Executives • Association for Professionals in Infection Control and Epidemiology • Infectious Diseases Society of America • Society for Healthcare Epidemiology of America

o Public Reporting Task Force, 2005 o Public Policy and Government Affairs Committee, 2005‐

• Alpha Omega Alpha Medical Honor Society • Pi Alpha Alpha National Public Affairs and Administration Honor Society • Physicians for a National Health Program

8. SPECIAL AWARDS, FELLOWSHIPS AND OTHER HONORS: 8.1 Awards

• Top Doctors in Richmond, 2008, Richmond Magazine • Best Teacher Award for Population Medicine, VCU, 2006‐2007 • Excellence in Patient Safety Award, Virginians Improving Patient Care and Safety, 2007 • Best Teacher Award for Population Medicine, VCU, 2005‐2006 • Top Doctors in Richmond, 2006, Richmond Magazine • Best Teacher Award for Population Medicine, VCU, 2004‐2005 • Best Teacher Award for Population Medicine, VCU, 2003‐2004 • Outstanding Teacher Award for Microbiology, VCU, 2003‐2004 • Outstanding Leadership Award, Department of Preventive Medicine, VCU, 2003 • Young Internist Award, Virginia Chapter, American College of Physicians, 2003 • Pi Alpha Alpha, National Public Affairs and Administration Honor Society, 2003 • Outstanding Master of Public Administration Student Award, VCU, 2003 • Outstanding Teacher Award for Population Medicine, VCU, 2001 • Five‐Year Teaching Award, Department of Internal Medicine, VCU, 2000 • Outstanding Teacher for Microbiology, VCU, 2000‐2001 • Best Teacher Award for Population Medicine, VCU, 2000‐2001


- 3 -

• Outstanding Teacher for Population Medicine, VCU, 1998‐1999 • Best Abstract Award, Association of Program Directors in Internal Medicine, 1998 • SHEA Trainee Award, Society for Hospital Epidemiology of America, 1994 • Best Teaching Resident Award, Department of Medicine, West Virginia University,

1988‐1989 • Outstanding Housestaff Award, Department of Medicine, West Virginia University,

1988‐1989 • Alpha Omega Alpha Medical Honor Society, 1988 • Outstanding Housestaff Award, Department of Medicine, West Virginia University,

1987‐1988 • Outstanding Resident in General Internal Medicine Clinic, West Virginia University,

1986‐1987 • Best Teaching Intern Award, West Virginia University, 1986‐1987 • Robert H. Waldman, MD Award for Academic Excellence, Department of Medicine,

West Virginia University, 1986‐1987 • Ciba Award for Outstanding Community Service, West Virginia University, 1984

8.2 Fellowships:

• Fellow, American College of Physicians • Fellow, Society for Healthcare Epidemiology of America • Fellow, Infectious Diseases Society of America

8.3 External Funding:

• Surveillance and control of pathogens of epidemiologic importance (SCOPE).Co‐investigator. Funding source: Aventis, Merck, Pfizer. (completed)

• VRE Nosocomial Bloodstream Infections: Descriptive Epidemiology. Co‐investigator. Funding source: Intrabiotics. (completed)

• Attributable morbidity and mortality of vancomycin‐resistant enterococcal bacteremia. Principal investigator. Funding source: Rhône‐Poulenc Rorer (completed)

• Candidemia in the surgical intensive care unit: determining risk factors. Co‐investigator. Funding source: Pfizer Pharmaceuticals (completed)

• Co‐colonization with methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant enterococcus. Co‐investigator. Funding source: Rhône‐Poulenc Rorer (completed)

• Controlled trial of universal gloving in the critical care setting. Co‐investigator. Funding source: Cardinal Healthcare.

• Use of sensor technology and wireless telemetry to monitor hand hygiene compliance in the inpatient setting. Funding source: BioVigil, LLC.

9.0 Invited Seminars: (only extramural presentations are listed) • Vaccines for Health Care Workers, Infection Control Symposium, Ball Memorial

Hospital, Muncie, Indiana, 11/94 • Surveillance & Control of Pathogens of Epidemiologic Importance, Critical Care

Infection Treatment Outcomes Project: Resistance Work Group, Philadelphia, Pennsylvania, 12/94


- 4 -

• The Impact of Epidemiologic Studies on Infection Control, Exploring the Critical Issues in Infectious Diseases, Sante Fe, NM, 3/95

• Vaccines for Health Care Workers, Three Rivers Assoc. of Infection Control Professionals Meeting, Pittsburgh, PA, 3/95

• Vancomycin Resistant Enterococcal Infections, Department of Medicine Meeting, Mercy Hospital, Iowa City, IA, 4/95

• Surveillance & Control of Pathogens of Epidemiologic Importance, Iowa State Infection Control Meeting, Iowa City, IA, 5/95

• Vaccines for the International Traveler, Department of Medicine Meeting, Muscatine General Hospital, Muscatine, IA, 6/95

• Vancomycin Resistant Enterococcal Infections, Association of Infection Control Professionals Regional Meeting, Pittsburgh, PA, 10/95

• Vancomycin Resistant Enterococcal Infections, Internal Medicine Grand Rounds, McKeesport Hospital, McKeesport, PA, 10/95

• Vancomycin Resistant Enterococcal Infections, Internal Medicine Grand Rounds, The Western Pennsylvania Hospital, Pittsburgh, PA, 10/95

• Vancomycin Resistant Enterococci: The Beginning of the End?, Internal Medicine Grand Rounds, West Virginia University Hospitals, Morgantown, WV, 10/95

• Vancomycin Resistant Enterococcal Infections, Greensville Hospital, Emporia, VA, 12/95

• Impact of Vancomycin Resistant Enterococci on Acute & Long‐term Care Facilities, League of Intravenous Therapy Education National Meeting, Pittsburgh, PA, 2/96

• Session Moderator: Vancomycin Resistant Enterococci, Society for Healthcare Epidemiology of America Meeting, Washington, DC, 4/96

• Preparing the International Traveler, Society for General Internal Medicine Meeting, Washington, DC, 5/96

• The Moonlighting Resident: How Much is Too Much?, MCV Regional Chief Resident Training Course, Richmond, VA, 5/96

• Antimicrobial Resistance in the Critical Care Setting, Roussel New Zealand Antimicrobial Workshop, Auckland, New Zealand, 5/96

• The Use of Epidemiologic Data in Controlling ICU Nosocomial Infections, Roussel New Zealand Antimicrobial Workshop, Auckland, New Zealand, 5/96

• Sharps Injuries in Health Care Workers, Roussel New Zealand Antimicrobial Workshop, Auckland, New Zealand, 5/96

• Current Trends in Nosocomial Infections, Medical Science Lecture, Auckland General Hospital, Auckland, New Zealand, 5/96

• The Epidemiology of Vancomycin Resistant Enterococcal Infections, National Meeting, Society for Infection Control of Mexico, Mexico City, Mexico, 9/96

• National Surveillance for Nosocomial Infections, National Meeting, Society for Infection Control of Mexico, Mexico City, Mexico, 9/96

• Vancomycin‐Resistant Enterococci, Medical Staff Meeting, Lucy Corr Nursing Home, Richmond, VA, 9/96

• Update on Endocarditis, 6th Annual Infectious Disease Symposium, Taos, NM, 9/96

• Fever, 6th Annual Infectious Disease Symposium, Taos, NM, 9/96


- 5 -

• Vancomycin‐Resistant Enterococci, 6th Annual Infectious Disease Symposium, Taos,

NM, 9/96 • Risk Factors for and Treatment of Infections due to Methicillin‐Resistant

Staphylococcus aureus, International Congress of Hospital Infections, Cali, Colombia, 11/96

• Epidemiology of Vancomycin‐Resistant Enterococcal Infections, International Congress of Hospital Infections, Cali, Colombia, 11/96

• Nosocomial Fungal Infections, International Congress of Hospital Infections, Cali, Colombia, 11/96

• Controlling New Nosocomial Pathogens, Internal Medicine Grand Rounds, Nassau County Medical Center, Long Island, NY, 1/97

• Historical and Future Perspectives on Gram Positive Aerobic Antimicrobial Resistance, Workshop on Gram Positive Aerobic Resistance in the ICU, Society for Critical Care, San Diego, CA, 2/97

• New Developments in the Management of Sharps Injuries, Department of Surgery, Williamsburg Community Hospital, Williamsburg, VA, 2/97

• Symposium on Infection Control for Long‐Term Care Facilities, Virginia Healthcare Association, Richmond, VA, 3/97

• Moving the Hospital, Moving the Bugs: Infection Control in Ambulatory Settings, Canadian Infection Control Meeting, Quebec City, Quebec, 4/97

• Session Moderator: Antibiotic Resistance—Counterattack, Society for Healthcare Epidemiology of America Meeting, St. Louis, MO, 4/97

• Epidemiology of Antibiotic‐Resistant Infections, Plenary Session, Society for Healthcare Epidemiology of America Meeting, St. Louis, MO, 4/97

• Workshop: Problem Pathogens—MRSA and VRE: Practical Tips for the Healthcare Epidemiologist, Society for Healthcare Epidemiology of America Meeting, St. Louis, MO, 4/97

• Antimicrobial Resistance: Overview and Impact, Symposium on Antimicrobial Resistance, Cedars‐Sinai Medical Center, Los Angeles, CA, 5/97

• The SCOPE Project, National Meeting, Association of Professionals in Infection Control, New Orleans, LA, 5/97

• Finding a Job in Infectious Diseases, Infectious Diseases Fellows Conference, San Francisco, CA, 9/97

• Vancomycin Resistant Staphylococcus aureus, Workshop on Antibiotic Surveillance Studies: Clinical Utility, San Francisco, CA, 9/97

• Antibiotic Resistance: An Overview, Internal Medicine Grand Rounds, Central Maine Medical Center, Lewiston, ME, 10/97

• Antibiotic Resistant Pathogens: Bugs and Thugs, Regional Conference, Association of Infection Control Professionals, Long Island, NY, 11/97

• Epidemiology of Gram Positive Bacterial Infections in Cancer Patients, Synercid Oncology Advisory Board Meeting, New York, NY, 11/97

• Epidemiology of Antibiotic‐Resistant Gram‐Positive Organisms, Anti‐Infective Drugs Advisory Committee Meeting, Food and Drug Administration, Gaithersburg, MD, 2/98

• Antibiotic Resistant Pathogens, League of Intravenous Therapy Education National Meeting, Pittsburgh, PA, 2/98


- 6 -

• Epidemiology of Antibiotic‐Resistant Infections: Round Table Discussion, Virginia Infectious Diseases Society, Irvington, VA, 3/98

• Overview of the SCOPE Project, SCOPE Network Update Symposium, Orlando, FL, 4/98 • Bloodborne Pathogens and the Healthcare Worker, Ismaili Health Professionals’

Association Meeting, Houston, TX, 5/98 • Point‐Counterpoint: Are Isolation Precautions Necessary to Prevent the Transmission

of Multi‐Drug Resistant Organisms? National Meeting, Association of Professionals in Infection Control, San Diego, CA, 5/98

• Vancomycin‐Intermediate Staphylococcus aureus: Control Strategies, International Congress on Infectious Diseases, Boston, MA, 5/98

• Epidemiology of Serious Gram‐Positive Infections, International Congress on Infectious Diseases, Boston, MA, 5/98

• Controlling Glycopeptide‐Resistant Staphylococci, Richmond Area Infection Control Professionals Meeting, Richmond, VA, 6/98

• VISA/VRSA: Those Vicious Villains, Audioconference, Texas Association for Professionals in Infection Control, 8/98

• Vancomycin‐Resistant Staphylococcus aureus, MD‐TV Emerging Pathogens Teleconference, Robert C. Byrd Health Sciences Center at West Virginia University, Morgantown, WV, 9/98

• Antibiotic Resistance: An Overview and Update, Internal Medicine Grand Rounds, McNeal Hospital, Chicago, IL, 9/98

• Gram‐Positive Infections in the Cancer Patient, Infectious Diseases Fellows Course, Memorial Sloan‐Kettering Cancer Center/New York Hospital‐Cornell Medical Center, New York, NY, 10/98

• MRSA & VRE: Problem Pathogens in Long‐Term Care, Virginia Healthcare Association Conference, Richmond, VA, 10/98

• Antibiotic Resistance, Internal Medicine Grand Rounds, University of Tennessee College of Medicine, Memphis, TN, 10/98

• Epidemiology of Antibiotic‐Resistant Gram‐Positive Organisms, International Meeting on the Therapy of Infections, Florence, Italy, 11/98

• Controlling Vancomycin‐Resistant Enterococci, Infectious Diseases Grand Rounds, University of Texas, Southwestern, Dallas, TX, 3/99

• Epidemiology of Antibiotic‐Resistant Gram‐Positive Organisms, Infectious Diseases Grand Rounds, St. John’s Medical Center, Detroit, MI, 3/99

• An Overview of Antibiotic Resistance, Internal Medicine Grand Rounds, Wilford Hall Medical Center, Lackland AFB, TX, 3/99

• Epidemiology of Nosocomial Multidrug‐Resistant gram‐Positive Infections, Linezolid US Multidisciplinary Marketing Consultants Meeting, Orlando, FL, 4/99

• Antibiotic Resistance: Implications for the General Internist, National Meeting, American College of Physicians, New Orleans, LA, 4/99

• Nosocomial Infections Update, Daytona Beach Annual Infectious Disease Conference, Daytona Beach, FL, 5/99

• Medical Waste, Solid Waste Subcommittee, The Future of Virginia’s Environment, General Assembly of the Commonwealth of Virginia, Richmond, VA, 8/99

• Managing VRE Infections in Your Hospital, Meet‐the‐Expert Symposium, Interscience


- 7 -

Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 9/99 • Yes, Virginia, There is Rabies! Virginia Meeting, Association for Professionals in

Infection Control, Williamsburg, VA, 10/99 • Epidemiology of Multidrug‐Resistant Gram‐Positive Organisms, National

Videoconference, National Foundation for Infectious Diseases, Atlanta, GA, 10/99 • Vancomycin‐Intermediate S. aureus Infections, Infectious Diseases 2000 Conference,

Phoenix, AZ, 10/99 • The Dishonest Dean’s Letter, American Association of Medical Colleges Meeting,

Washington, DC, 10/99 • Dual Physician Couples in the Residency Program, Association of Program Directors in

Internal Medicine, Washington, DC, 10/99 • Infection Control Issues in Long‐Term Care, University of Texas Audioconference, 1/00 • Nosocomial Bacteremias in US Hospitals: The SCOPE Project, SCOPE 2000 Meeting,

Atlanta, GA, 3/00 • Controlling Staphylococcus aureus, CDC/SHEA Decennial Conference on Nosocomial

Infections, Atlanta, GA, 3/00 • Antibiotic Resistance: Minicourse, National Meeting, American College of Physicians,

Philadelphia, PA, 4/00 • Preventing Transmission of Resistant Agents in the Hospital, Distinguished Lecture,

National Meeting, American College of Physicians, Philadelphia, PA, 4/00 • Vancomycin Tolerance and Resistance among Gram‐Positive Cocci, 2nd Annual

Conference on Gram‐Positive Cocci Infections in Humans, Las Vegas, NV, 5/00 • Epidemiology of Resistant Gram‐Positive Infections, American Society for

Microbiology Satellite Symposium, Los Angeles, CA, 5/00 • Surveillance for Infections in Long‐Term Care, State Meeting, Association of

Professionals in Infection Control, Richmond, VA, 10/00 • Vancomycin‐Resistant Enterococci: Epidemiology and Control, Infectious Diseases

Grand Rounds, Vanderbilt University Medical School, Nashville, TN, 10/00 • Macrolide‐Resistant Pneumococci, Aventis Ketolide Advisory Group, Boston, MA, 3/01 • Epidemiology of Gram‐Positive Infections, Fellows Teaching Conference, Memorial

Sloan‐Kettering Cancer Center, New York, NY, 1/02 • Infectious Diseases Emergencies, John Randolph Hospital, Hopewell, VA, 1/02 • Influenza Update, Southside Regional Hospital, Petersburg, VA, 1/02 • The Impact of Confusing Skin Contamination and Device Colonization with Clinical

Infection, Society of Healthcare Epidemiology Satellite Symposium, Salt Lake City, UT, 4/02

• Controlling Antibiotic‐Resistant Pathogens: Laissez‐faire or Search and Destroy, Internal Medicine Grand Rounds, West Virginia University, Morgantown, WV, 4/02

• Multidrug Resistant Pathogens: Infection Control Implications, Three Rivers Association of Professionals in Infection Control, Pittsburgh, PA, 4/02

• Development of Policy on Pre‐Event Smallpox Vaccination, Audioconference, National Association of Public Hospitals, 1/03

• Development of Policy on Pre‐Event Smallpox Vaccination, Audioconference, Association of American Medical Colleges, 2/03

• Wound Infections and Osteomyelitis, Wound Care Conference, Richmond, VA, 3/03


- 8 -

• Smallpox: The Disease, the Vaccine and the Controversy, John Randolph Hospital, Hopewell, VA, 3/03

• Smallpox: The Disease, the Vaccine and the Controversy, Greensville Memorial Hospital, Emporia, VA, 4/03

• Smallpox: The Disease, the Vaccine and the Controversy, Southside Regional Hospital, Petersburg, VA, 4/03

• Smallpox: The Disease, the Vaccine and the Controversy, Medical‐Surgical Nurses Conference, Richmond, VA, 4/03

• Smallpox, Virginia Chapter Meeting, American College of Physicians, Richmond, VA, 4/03

• VCU Health System Approach to Pre‐Event Smallpox Vaccination, Committee on Smallpox Vaccination Program Implementation, Institute of Medicine, Washington, DC, 5/03

• Community Acquired Pneumonia: Indicators for Quality Care, Virginia Health Quality Center Regional Conference, Richmond, VA, 6/03

• Influenza. Virginia Health Quality Center Regional Conference, Richmond, VA, 9/03 • Infection Control, Meet the Professor, Infectious Diseases Society of America Meeting,

San Diego, CA, 10/03 • Epidemiology of Colonization and Infection with Vancomycin Resistant Enterococci,

FDA Advisory Panel, Gaithersburg, MD, 10/03 • Infection Control Practices to Improve Patient Care, Hospital Corporation of America,

Design Session to Prevent Hospital Acquired Infections, Nashville, TN, 10/03 • Influenza Update, Mary Washington Hospital, Fredericksburg, VA, 1/04 • Influenza Update, Henrico Doctor’s Hospital, Richmond, VA, 2/04 • Smallpox: The Disease, The Vaccine and the Controversy, Virginia Society for

Radiologic Technologists Annual Seminar, Richmond, VA, 5/04 • Epidemiology and Prevention of Acinetobacter Infections in the ICU. Infections in

Critical Patients Meeting, Florence, Italy, 6/04 • Hospital Epidemiology: Infections You Can Pick Up in the Hospital, VCU Mini‐Med

School, Science Museum of Virginia, Richmond, VA, 9/04 • Mandatory Reporting and Disclosure of Nosocomial Infections: Operational and

Technical Issues, Virginia Department of Health Expert Panel, 09/04 • Search and Destroy: The Dark Side, Three Rivers Association of Professionals in

Infection Control, Pittsburgh, PA, 10/04 • Mandatory Reporting and Disclosure of Nosocomial Infections: Operational and

Technical Issues, Richmond Association of Professionals in Infection Control, 10/04 • Search and Destroy: The Dark Side, North Carolina Infectious Diseases Society,

Greensboro, NC, 11/04 • Mandatory Reporting and Disclosure of Nosocomial Infections, Maryland Infection

Control Network Conference, 2/05 • Public Reporting: Provider’s Perspective, Where the Rubber Hits the Road. Opening

Plenary Session, Society for Healthcare Epidemiology of America, Los Angeles, CA, 4/05

• Session moderator: Surveillance: The Day after Tomorrow, Society for Healthcare Epidemiology of America, Los Angeles, CA, 4/05


- 9 -

• Mandatory Reporting of Nosocomial Infections, Arizona State Association of Professional in Infection Control Meeting, 09/05

• Search and Destroy: The Dark Side, Virginia Association of Professionals in Infection Control, Richmond, VA, 10/05

• Public Reporting: How to Influence the Final Product. Society for Healthcare Epidemiology of America, Chicago, IL, 03/06

• Global Epidemiology and Surveillance. Clinical Tropical Medicine and Parasitology Course, West Virginia University, 06/06

• Infectious Disease Epidemiology. Clinical Tropical Medicine and Parasitology Course, West Virginia University, 06/06

• Community acquired MRSA infections. Infectious Diseases in Primary Care Conference, Iowa City, IA, 04/07

• Session moderator: New Insights into MRSA Screening and Reporting. Society for Healthcare Epidemiology of America, Baltimore, MD, 04/07

• Session moderator: Use of Active Surveillance Cultures. Society for Healthcare Epidemiology of America, Baltimore, MD, 04/07

• Mandatory Reporting of Healthcare Quality Data. Virginia Mandatory Reporting Conference. Charlottesville, VA, 05/07

• Mandatory Reporting of Nosocomial Infections, Plenary Session, Council of State and Territorial Epidemiologists National Meeting, Atlantic City, NJ, 06/07

• Global Epidemiology and Surveillance. Clinical Tropical Medicine and Parasitology Course, West Virginia University, 06/07

• Infectious Disease Epidemiology. Clinical Tropical Medicine and Parasitology Course, West Virginia University, 06/07

• Infection Control for the Surgeon. Surgery Grand Rounds, West Virginia University, 07/07

• Active Surveillance for MRSA: Implications for Safety Net Hospitals. Teleconference, National Association of Public Hospitals, 09/07

• Infection Control 2007: Shifting Paradigms. Anthony DiBartolomeo, MD Endowed Lectureship. Internal Medicine Grand Rounds, West Virginia University, 09/07

• Search and Destroy: The Dark Side. Virginia Association of Professionals in Infection Control. Newport News, VA, 10/07

• Active Surveillance for MRSA. Annual Meeting of the Medical Society of Virginia, The Homestead, VA, 10/07

• Infection Control 2007: Shifting Paradigms. Virginia Nurses Association, Richmond, VA, 10/07

• Healthcare Associated Infections: Considerations for Measuring and reporting. Virginia Hospital and Healthcare Association, Richmond, VA 02/08

• Nurse Sensitive Measures: Healthcare Associated Infections. Anthem Blue Cross/Blue Shield Quality Insights Hospital Improvement Program, Richmond, VA, 03/08

• Getting to Zero: Unintended Consequences. Opening Plenary Session of the Society for Healthcare Epidemiology Annual Meeting, Orlando, FL, 04/08

• Mandatory Reporting of Healthcare Associated Infections. Virginia Department of Health Epidemiologists Meeting, Richmond, VA, 04/08

• Active Surveillance for MRSA. California Infectious Diseases Society, Dana Point, CA,


- 10 -

05/08 • Challenges of Surveillance, Epidemiology and Public Reporting in the Healthcare

Setting. Southeastern Center for Emerging Biologic Threats Conference on Healthcare Infections Associated with the Care and Treatment of Humans and Animals, Atlanta, GA, 05/08

• Public Reporting of Healthcare Associated Infections: The Virginia Experience. Southeastern Center for Emerging Biologic Threats Conference on Healthcare Infections Associated with the Care and Treatment of Humans and Animals, Atlanta, GA, 05/08

• The role of active surveillance cultures for MRSA, Texas Infectious Diseases Society, San Antonio, TX, 06/08

• MRSA Search and Destroy: The Dark Side. Grand Rounds, Mary Washington Hospital, Fredericksburg, VA, 06/08

• Controlling MRSA without Active Surveillance. Virginia Association of Healthcare Quality Meeting, Wintergreen, VA. 10/08

10. COMMITTEES: 10.1 University and Hospital 1994‐95 Resident Evaluation Committee, Department of Internal Medicine, University of

Iowa 1994‐95 Laboratory Advisory Subcommittee, University of Iowa Hospitals 1995 Drug Use Evaluation Subcommittee, University of Iowa Hospitals 1995 Antibiotic Advisory Subcommittee, University of Iowa Hospitals 1995‐ Anti‐infectives Monitoring Subcommittee, MCVH 1995‐01 Residency Program Directors Council, MCVH 1995‐96 Medical Staff Quality Assessment and Improvement Committee, MCVH 1995‐ Infection Control Committee, MCVH 1995‐01 Clinical Competency Committee, Dept. of Internal Medicine, VCU 1995‐01 Curriculum Committee, Dept. of Internal Medicine, VCU 1995‐01 Intern Selection Committee, Dept. of Internal Medicine, VCU 1995‐ Performance Improvement Council, MCVH 1996‐97 MIDS Steering Committee, MCVH 1996‐99 Multidisciplinary Working Group on Cardiothoracic Surgical Wound Infections,

MCVH 1995‐97 Medical Staff AIDS Committee, MCVH 1995‐97 JCAHO Infection Control Functional Team, Co‐Leader, MCVH 1995‐97 Tuberculosis Task Force, MCVH 1996 Emergency Admission Review and Transition Help Group, MCVH 1996 MCV/VA Relations Committee, Department of Internal Medicine, VCU 1997 Ad hoc Committee on Housestaff Ambulatory Continuity Experience, Chair,

Department of Internal Medicine, VCU 1997 Microbiology Curriculum Renewal Subgroup, VCU School of Medicine 1997‐98 Search Committee for Chief of the Medical Service, Hunter Holmes McGuire VA

Medical Center


- 11 -

1996‐ Graduate Medical Education Committee, MCVH 1997‐ Expert Panel for Issues Related to Bloodborne Pathogen Infected Health Care

Professionals and Students, VCU 1997‐99 Education Subcommittee to the Graduation Education Committee, VCU 1997‐ Postexposure Prophylaxis Management Team, MCVH 1997 Hepatitis C Lookback Ad Hoc Committee, MCVH 1998‐ Medical Student Promotions Committee, VCU 1998 Chair, Internal Review Committee for Obstetrics and Gynecology Residency

Program, MCVH 1998 Chair, Internal Review Committee for Preventive Medicine Residency Program,

MCVH 1999 Alternatives to Care for Emergency Department Patients Task Force, MCVH 1999 Information Systems Working Group, Department of Internal Medicine, VCU 2000 Emergency Room Diversion Task Force, MCVH 2000 Preventive Medicine Chair Search Committee, VCU School of Medicine 2001 Internal Review Committee for Cardiothoracic Surgery Fellowship, VCU 2001 Conflict of Interest Work Group, VCU 2001 Outcomes Research Institute Advisory Panel, VCU 2002‐03 Central Venous Catheterization Task Force, MCVH 2002‐03 Residency Advisory Committee, Department of Preventive Medicine, VCU 2002‐ Disaster Preparedness Committee, MCVH 2002‐03 Smallpox Vaccination Evaluation Committee, MCVH 2003 Chair, Internal Review Committee, Dermatology Residency Program, VCU 2003‐ Epidemiology PhD Oversight Committee, VCU 2003‐04 Chair, Internal Medicine Residency Director Search Committee, VCU 2003 School of Public Health Task Force Committee, VCU 2003‐ Resident Work Life Committee, VCU Health System 2003‐ Critical Incident Review Team, Co‐Chair, VCU Health System 2004‐ VCU Public Health Response Team 2005 Clinical Practice Council, MCV Physicians (Practice Plan) 2006‐ Critical Care Committee, VCU Health System 2006‐ M3 Committee, Department of Internal Medicine, VCU 2006‐ Search Committee, Faculty in Epidemiology and Community Health 2008‐ Safety Initiative Medical Advisory Group, VCU Health System

10.2 Professional – panels, boards, councils 1996‐98 Question writer and reviewer, Infectious Diseases Certifying Examination, American Board of Internal Medicine 1996 Course Director, MCV Regional Chief Medical Resident Training Course, Richmond,

VA 1997 Co‐Chair, Program Committee, Virginia Chapter, American College of Physicians

Annual Meeting 1997 Regulation Review Advisory Committee for Disease Reporting and Control,

Commonwealth of Virginia Department of Health 1997 Pfeisteria Medical Evaluation Team, Commonwealth of Virginia Department of

Health


- 12 -

1998‐ M‐1, M‐2 Ethics Group Facilitator, VCU School of Medicine 1998 Education Merger Task Force, Virginia Chapters, American College of Physicians &

American Society of Internal Medicine 1998‐00 Abstract Reviewer, American College of Physicians National Associates

Competition 1998‐00 Abstract Reviewer, Association of Program Directors in Internal Medicine Poster

Competition 2000‐02 Secretary‐Treasurer, Brown‐Sequard Chapter, Alpha Omega Alpha Medical Honor

Society 2002‐05 Councilor, Brown‐Sequard Chapter, Alpha Omega Alpha Medical Honor Society 2002 Question Writer on Bioterrorism, United States Medical Licensure Examination 2002‐03 Advisory Committee on Bioterrorism Preparedness and Response, Virginia

Department of Health 2002‐03 Governor’s Secure Virginia Initiative, Health and Medical Subpanel Commonwealth of Virginia 2002‐03 Abstract Reviewer, American College of Physicians Virginia Associates Competition 2003 Committee on Personal Protective Equipment for Health Department Workers,

Virginia Department of Health 2004 Abstract Reviewer, Infectious Diseases Society of America Annual Meeting 2005‐06 Scientific Program Subcommittee for the national meeting of the American

College of Physicians, 2007 2005‐ Public Policy and Government Affairs Committee, Society for Healthcare

Epidemiology of America 2005‐06 Task Force on Mandatory Reporting of Healthcare‐Associated Infections, Society

for Healthcare Epidemiology of America 2006‐ Virginia Department of Health Pandemic Influenza Advisory Committee 2006 Anthem Blue Cross/Blue Shield Expert Advisory Panel to the Quality‐in‐Sights

Hospital Incentive Program 2006 Special Emphasis Panel (Study Section) on antimicrobial resistance research (R01,

U01), Centers for Disease Control and Prevention 2007 Centers for Disease Control and Prevention, Food and Drug Administration, and

National Institutes of Health Task Force on Antimicrobial Resistance 2007 Infection Control Consultant to the United States Secret Service 2008‐ Virginia Hospital and Healthcare Association Advisory Group on Quality/Safety

Initiatives 2008‐ Healthcare‐Associated Infections Advisory Group, Virginia Department of Health

10.3 Scholarly Journal Activity Ad hoc reviewer: American Journal of Infection Control, Clinical Infectious

Diseases, Infection Control and Healthcare Epidemiology, Journal of the American Medical Association, New England Journal of Medicine

11. OTHER SIGNIFICANT EXPERIENCES:


- 13 -

11.1 Graduate student trainees: 2002 Tammy Bischoff, MPH candidate 2003 Tammy Daniels, MD/MPH candidate

11.2 Postdoctoral trainees: 1995‐96 Tania Oliveira, MD, Fulbright Scholar, State University of Campinas,

Brazil 1996‐97 Dianne Franchi, MD, University of Connecticut 1996‐97 Werner Bischoff, MD, PhD, University of Hanover, Germany 1996‐98 Alice Wong, MD, MPH, University of Manitoba, Canada 1997‐98 Marcus Coimbra, PhD, University of Rio de Janeiro, Brazil 1998, 2002 Hilmar Wisplinghoff, MD, PhD, University of Cologne, Germany 2000‐02 Eric Young, MD, Boston University 2001‐02 Heikke von Baum, MD, University of Heidelberg, Germany 2004‐05 Alexandre Marra, MD, University of Sao Paulo, Brazil 2005‐07 Susan Assanasen, MD, Mahidol University, Bangkok, Thailand 2007‐ Michael Stevens, MD, Virginia Commonwealth University

11.3 Doctoral Dissertation Committees: 2006‐07 Deborah Jefferson, VCU School of Nursing 2006‐07 Suzanne Phillips, VCU School of Pharmacy

11.4 Masters Thesis Committees:

2007 J. Patrick Powell, VCU School of Pharmacy

11.5 Major teaching assignments: 2002, 2003 Co‐Director, Bioterrorism and Public Health Preparedness Course

(Preventive Medicine 693), VCU 2005 Co‐Director, Contemporary and Controversial Issues in Public

Health (Epidemiology 693), VCU 12. BIBLIOGRAPHY:

12.1 Papers published 1. Edmond MB, Khakoo RA, McTaggart B, Solomon R. Effect of bedside needle disposal units

on needle recapping frequency and needlestick injury. Infection Control and Hospital Epidemiology 1988;9:114‐116.

2. Sundberg R, Shapiro R, Darras F, Jensen C, Scantlebury V, Jordan M, McCauley J, Kusne S, Edmond MB, Ho M, Jereb J, Burwen D, Medvick J, Pasculle W, Hakala T, Simmons RL, Starzl TE. A tuberculosis outbreak in a renal transplant program. Transplantation Proceedings 1991;23:3091‐3092.

3. Edmond MB, Wenzel RP. Ethical considerations in the use of subliminal stimulation to improve handwashing compliance: Scientific utility vs. autonomy of the individual. Infection Control and Hospital Epidemiology 1993;14:107‐109.

4. Edmond MB, Riddler SA, Baxter CM, Wicklund BM, Pasculle AW. Agrobacterium


- 14 -

radiobacter: A recently recognized opportunistic pathogen. Clinical Infectious Diseases 1993;16:388‐391.

5. Rangel‐Frausto MS, Edmond MB. Malaria: Protection of the international traveler. Infection Control and Hospital Epidemiology 1993;14:155‐160.

6. Green M, Binczewski B, Pasculle AW, Edmond M, Barbadora K, Kusne S, Schlaes DM. Constitutively vancomycin‐resistant Enterococcus faecium resistant to synergistic ß‐lactam combinations. Antimicrobial Agents and Chemotherapy 1993;37:1238‐1242.

7. Jereb JA, Burwen DR, Jarvis WR, Dooley SW, Haas WH, Crawford JT, Geiter LJ, Edmond MB, Dowling JN, Shapiro R, Pasculle AW, Shanahan SL, Jarvis WR. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. Journal of Infectious Diseases 1993;168:1219‐1924.

8. Edmond MB, Ober JF, Weinbaum DL, Sanford MD, Pfaller MA, Hwang T, Wenzel RP. Vancomycin‐resistant Enterococcus faecium bacteremia: Risk factors for infection. Clinical Infectious Diseases 1995; 20:1126‐1130.

9. Edmond MB, Hollis RJ, Houston AK, Wenzel RP. Molecular epidemiology of meningococcal disease in a university community. Journal of Clinical Microbiology 1995; 33: 2209‐2211.

10. Edmond MB. The impact of epidemiologic studies on infection control. Clinical Performance and Quality Health Care 1995;3:233.

11. Edmond MB, Wenzel RP, Pasculle AW. Vancomycin‐resistant Staphylococcus aureus: Perspectives on measures needed for control. Annals of Internal Medicine 1996;124:329‐334. Reply to correspondence: Annals of Internal Medicine 1996;125:859‐860.

12. Lyckholm LJ, Edmond MB. Images in Clinical Medicine: Seasonal hemolysis due to cold‐agglutinin syndrome. New England Journal of Medicine 1996;334:437.

13. Muder RR, Harris AP, Muller S, Edmond MB, Chow JW, Papadakis K, Wagener MW, Bodey GP, Steckelberg JM. Bacteremia due to Stenotrophomonas maltophilia: A prospective, multicenter study of 91 episodes. Clinical Infectious Diseases 1996;22:508‐512.

14. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin‐resistant enterococcal bacteremia: natural history and attributable mortality. Clinical Infectious Diseases 1996;23:1234‐9.

15. Edmond MB. Multidrug‐Resistant Enterococci and the Threat of Vancomycin‐Resistant Staphylococcus aureus. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 3rd edition. Baltimore: Williams and Wilkins, 1997:339‐355.

16. Doebbeling BN, Edmond MB, Davis CS, Woodin JR, Zeitler RR. Influenza vaccination of health care workers: evaluation of factors that are important in acceptance. Preventive Medicine 1997;26:68‐77.

17. Wenzel RP, Edmond MB, Nettleman MD. Hospital Epidemiology—1997. Virginia Medical Quarterly 1997;124:103‐104.

18. Wenzel RP, Edmond MB. Tuberculosis infection after bronchoscopy. Journal of the American Medical Association, 1997;278:1111.

19. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP. Inducible AmpC �‐lactamase producing gram‐negative bacilli from bloodstream infections: Frequency, antimicrobial susceptibility and molecular epidemiology in a national surveillance program (SCOPE). Diagnostic Microbiology and Infectious Diseases 1997;28:211‐219.

20. Pfaller MA, Jones RN, Marshall SA, Edmond MB, Wenzel RP and the SCOPE Hospital Study


- 15 -

Group. Nosocomial streptococcal blood stream infections in the SCOPE Program: Species occurrence and antimicrobial resistance. Diagnostic Microbiology and Infectious Disease 1997;29:269‐263.

21. Jones RN, Marshall SA, Pfaller MA, Wilke WW, Hollis RJ, Erwin ME, Edmond MB, Wenzel RP. Nosocomial enterococcal bloodstream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results and laboratory testing accuracy. Diagnostic Microbiology and Infectious Diseases 1997;29:95‐102.

22. Wilke WW, Marshall SA, Coffman SL, Pfaller MA, Edmond MB, Wenzel RP, Jones RN. Vancomycin‐resistant Enterococcus raffinosus: Molecular epidemiology, species identification error and frequency of occurrence in a national resistance surveillance program (SCOPE). Diagnostic Microbiology and Infectious Diseases 1997; 29:43‐49.

23. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagnostic Microbiology and Infectious Diseases 1998;31:327‐332.

24. Herwaldt LA, Swartzendruber SK, Edmond MB, Embrey R, Kuhns KR, Wilkerson KR, Wenzel RP, Perl TM. The epidemiology of hemorrhage related to cardiothoracic surgery. Infection Control and Hospital Epidemiology 1998;19:9‐16.

25. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP and the SCOPE Participant Group. National surveillance of nosocomial bloodstream infection due to species of Candida other than Candida albicans. Diagnostic Microbiology and Infectious Diseases 1998;30:121‐129.

26. Pfaller MA, Lockhart SR, Pujol C, Swails‐Wenger JA, Messer SA, Edmond MB, Jones RN, Wenzel RP, Soll DR. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. Journal of Clinical Microbiology 1998;36:1518‐1529.

27. Wendt C, Ruden H, Edmond M. Vancomycin‐resistant enterococci: Epidemiology, risk factors, and prevention. Deutsches Ärzteblatt 1998;25:A1604‐A1611.

28. Rollins LK, Martindale JR, Edmond M, Manser T, Scheld WM. Using logistic regression to predict pass rates on the American Board of Internal Medicine Certifying Examination using the Internal Medicine In‐Training Examination. Journal of General Internal Medicine 1998;13:414‐416.

29. Wenzel RP, Edmond MB. Vancomycin‐Resistant Staphylococcus aureus: Infection Control Considerations. Clinical Infectious Diseases 1998;27:245‐251.

30. Wenzel RP, Edmond MB. The evolving technology of venous access. New England Journal of Medicine 1999;340:48‐50.

31. Edmond MB, Wallace SE, McClish DA, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in U.S. hospitals: A three‐year analysis. Clinical Infectious Diseases 1999;29:239‐244.

32. Edmond M, Roberson M, Hasan N. The dishonest dean’s letter: An analysis of 532 dean’s letters from 99 US medical schools. Academic Medicine 1999;74:1033‐1035. Reprinted in The Advisor: The Journal of the National Association of Advisors for the Health Professions 2001;21:13‐16.

33. Franchi D, Wong A, Edmond MB, Wenzel RP. Seeking vancomycin‐resistant Staphylococcus aureus among patients with vancomycin‐resistant enterococci. Clinical Infectious Diseases 1999;29:1566‐1568.

34. Bischoff WE; Reynolds TM, Hall GO, Wenzel RP, Edmond MB. Molecular epidemiology of vancomycin‐resistant Enterococcus faecium (VREF) strains in a large urban hospital over a


- 16 -

5‐year period. Journal of Clinical Microbiology 1999;37:3912‐3916. 35. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance

by health care workers: The impact of introducing an accessible, alcohol‐based hand antiseptic. Archives of Internal Medicine 2000;160:1017‐1021.

36. Wong AHM, Wenzel RP, Edmond MB. The epidemiology of bacteriuria due to vancomycin‐resistant enterococci—a retrospective study. American Journal of Infection Control 2000;28:277‐281.

37. Franchi D, Bahrani A, Ober JF, Edmond MB. Preventing nosocomial infections from gastrointestinal endoscopy. Current Gastroenterology Reports 2000;2:294‐298.

38. Heinemann B, Wisplinghoff H, Edmond M, Seifert H. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiolgocially defined Acinetobacter baumanii strains. Antimicrobial Agents and Chemotherapy 2000;44:2211‐2213.

39. Edmond MB. Transforming residency programs into high performance organizations. Click‐American College of Physician Executives Online Journal 2000;2. Available at http://www.acpe.org/Click/octoberclick/highperformance/edmondpage1.html.

40. Wisplinghoff H, Edmond MB, Pfaller MA, Wenzel RP, Seifert H. Nosocomial bloodstream infections due to Acinetobacter spp in US hospitals: clinical features, molecular epidemiology and antimicrobial susceptibility. Clinical Infectious Diseases 2000;31:690‐697.

41. Wenzel RP, Edmond MB. Managing antibiotic resistance. New England Journal of Medicine 2000;343:1961‐1963.

42. Edmond M. Glycopeptide‐resistant Staphylococcus aureus. International Journal of Clinical Practice 2000;supplement 115:66‐71.

43. Wenzel RP, Edmond MB. The impact of hospital‐acquired bloodstream infections. Emerging Infectious Diseases 2001;7:174‐177.

44. Wenzel RP, Gennings C, Edmond MB. Antifungal antibiotics and breakthrough bacteremias. Clinical Infectious Diseases 2001;32:1538‐1539.

45. Wisplinghoff H, Seifert H, Coimbra M, Wenzel RP, Edmond MB. Systemic Inflammatory Response Syndrome (SIRS) in adult patients with nosocomial bloodstream infection due to S. aureus. Clinical Infectious Diseases 2001; 33:733‐736.

46. Wenzel RP, Edmond MB. Severe sepsis—national estimates. Critical Care Medicine 2001; 29:1472‐1474.

47. Edmond MB, Deschenes JL, Eckler M, Wenzel RP. Racial bias in using USMLE Step 1 scores to grant internal medicine residency interviews. Academic Medicine 2001;76:1253‐1256.

48. Tallent SM, Bischoff T, Ostrowsky B, Climo M, Wenzel RP, Edmond MB. Vancomycin susceptibility of oxacillin‐resistant Staphylococcus aureus (ORSA) isolates causing nosocomial bloodstream infections. Journal of Clinical Microbiology 2002;40:2249‐2250.

49. Moellering RC, Craig W, Edmond M, Farrell DJ, Ferraro MJ, File TM Jr, Klein J, Lonks J, Metlay JP, Sahm D, Talbot GH. Clinical and public health implications of macrolide‐resistant Streptococcus pneumoniae. Journal of Chemotherapy 2002;14(suppl 3):42‐56.

50. Ostrowsky B, Ober J, Wenzel R, Edmond MB. The case of the cold thermometers. American Journal of Infection Control 2003;31:57‐59.

51. da Silva Coimbra MV, Silva‐Carvalho MC, Wisplinghoff H, Hall GO, Tallent S, Wallace S, Edmond MB, Figueiredo AM, Wenzel RP. Clonal spread of methicillin‐resistant Staphylococcus aureus in a large geographic area of the United States. Journal of Hospital Infection 2003;53:103‐110.


- 17 -

52. Wisplinghoff H, Seifert H, Wenzel RP Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in U.S. hospitals. Clinical Infectious Diseases 2003;36:1103‐1110.

53. Wenzel RP, Edmond MB. Managing SARS amidst uncertainty. New England Journal of Medicine 2003;348:1947‐1948.

54. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in nosocomial bloodstream infections in pediatric patients in U.S. hospitals: epidemiology, clinical features and susceptibilities. Pediatric Infectious Disease Journal 2003;22:686‐691.

55. Wenzel RP Edmond MB. Listening to SARS: lessons for infection control. Annals of Internal Medicine 2003;139:592‐593.

56. Gonzalez A, Bischoff T, Tallent S, Sheke G, Ostrowsky B, Edmond MB, Wenzel RP. Antibiotic resistance in the community. Journal of Hospital Infection 2003;55:156‐157.

57. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in United States hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 2004;39:309‐317.

58. Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Predicting hospital rates of fluoroquinolone‐resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clinical Infectious Diseases 2004;39:497‐503.

59. Rosato AE, Tallent SM, Edmond MB, Bearman GML. Susceptibility of coagulase‐negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine impregnated central venous catheter. American Journal of Infection Control 2004;32:486‐488.

60. Berhe M, Edmond MB, Bearman GML. An assessment of health care workers’ perceptions of compliance with infection control practices and knowledge of nosocomial infections. American Journal of Infection Control 2005;33:55‐57.

61. Wenzel RP, Edmond MB. Patient to patient transmission of hepatitis C. Annals of Internal Medicine 2005;142:940‐941.

62. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 United States hospitals. Clinical Infectious Diseases 2005;41;435‐40.

63. MacDougall C, Harpe SE, Powell JP, Johnson CK, Edmond MB, Polk RE. Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerging Infectious Diseases 2005;11:1197‐1204.

64. Edmond MB, White‐Russell MB, Woolard CD, Ober JF, Bearman GML. A statewide survey of nosocomial infection surveillance in acute care hospitals. American Journal of Infection Control 2005;33:480‐482.

65. Wenzel RP, Bearman GML, Edmond MB. Lessons from SARS: Implications for infection control. Archives of Medical Research 2005;36:610‐6.

66. Stevens MP, Edmond MB. Endocarditis due to vancomycin‐resistant enterococci: Case report and review of the literature. Clinical Infectious Diseases 2005;41:1134‐42.

67. Marra AR, Bearman G, Wenzel RP, Edmond MB. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. BioMed Central Infectious Diseases 2005;5:94.

68. von Baum H, Ober JF, Wendt C, Wenzel RP, Edmond MB. Antibiotic‐resistant nosocomial bloodstream infections: specific risk factors in a high risk population. Infection 2005;33:320‐6.


- 18 -

69. Marra AR, Pereira CAP, Gales AC, Menezes LC, Cal RGR, de Souza JMA, Edmond MB, Faro C, Wey SB. Bloodstream infections due to metallo‐β‐lactamase‐producing Pseudomonas aeruginosa: epidemiology, microbiology and clinical outcomes. Antimicrobial Agents and Chemotherapy 2006;5:388‐90.

70. Wisplinghoff H, Bischoff T, Seifert H, Wenzel RP, Edmond MB. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections due to Candida species. Clinical Microbiology and Infection 2006;12:170‐177.

71. Marra AR, Wey SB, Castelo A, Gales AC, Cal RGR, Filho JRC, Edmond MB, Pereira CAP. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended‐spectrum β‐lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infectious Diseases 2006;6:24.

72. Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman GML. Time to blood culture positivity as a predictor of clinical outcome in Staphylococcus aureus bloodstream infection. Journal of Clinical Microbiology 2006;44:1342‐1346.

73. Marra AR, Bar K, Bearman G, Wenzel RP, Edmond MB. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus species: Comparison of elderly and nonelderly patients. Journal of the American Geriatrics Society 2006;54:804‐808.

74. Marra AR, Major Y, Bearman GML, Edmond MB. Linezolid‐resistant, vancomycin‐susceptible Enterococcus faecalis central venous catheter colonization. Journal of Clinical Microbiology 2006;44:1915‐1916.

75. Marra AR, Bar K, Bearman GML, Wenzel RP, Edmond MB. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. Journal of Infection 2006;53:30‐35.

76. Marra AR, Bearman GML, Wenzel RP, Edmond MB. Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa 2006;6:132.

77. Bar K, Wisplinghoff H, Wenzel RP, Bearman GML, Edmond MB. Systemic inflammatory response associated with nosocomial enterococcal bloodstream infection. BMC Infectious Diseases 2006;6:145.

78. Berhe M, Edmond MB, Bearman G. Measurement and feedback of infection control process measures in the intensive care unit: impact on compliance. American Journal of Infection Control 2006;34:537‐539.

79. Wenzel RP, Edmond MB. Team‐based prevention of catheter‐related infections. New England Journal of Medicine 2006;355:2781‐2783.

80. Marra AR, Opilla M, Edmond MB, Kirby DF. Epidemiology of bloodstream infections in patients on long‐term total parenteral nutrition. Journal of Clinical Gastroenterology 2007;41:19‐28.

81. Diekema DJ, Edmond MB. Look before you leap: Active surveillance for multidrug‐resistant organisms. Clinical Infectious Diseases 2007;44:1101‐1107.

82. Heipel D, Ober J, Edmond MB, Bearman GML. Surgical site infection surveillance for neurosurgical procedures: a comparison of passive surveillance by surgeons to active surveillance by infection control professionals. American Journal of Infection Control 2007;35:200‐202.

83. Marra AR, Edmond MB, Wenzel RP, Bearman GML. Clostridium difficile‐associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC


- 19 -

Infectious Diseases 2007;7:42. 84. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of

catheter‐related bloodstream infections in home parenteral nutrition patients. Journal of Parenteral and Enteral Nutrition 2007;31:302‐305.

85. Edmond MB, Bearman GML. Mandatory public reporting in the USA: an example to follow? Journal of Hospital Infection 2007;65(S2):182‐188.

86. Wenzel RP, Bearman G, Edmond MB. Community‐acquired methicillin‐resistant Staphylococcus aureus: New issues for infection control. International Journal of Antimicrobial Agents 2007;30:210‐212.

87. Bearman G, Marra AR, Sessler CN, Smith WR, Rosato A, Wenzel RP, Edmond MB. A controlled trial of universal gloving vs. contact precautions for preventing the transmission of multidrug‐resistant organisms. American Journal of Infection Control 2007;35:650‐655.

88. Matsuyama R, Lyckholm L, Lowe E, Edmond MB. Beyond the IRB: Exploring ethical issues in psychosocial research. Monash Bioethics Review 2007;26:49‐59.

89. Edmond MB, Eickhoff TC. Who’s steering the ship? External influences on infection control programs. Clinical Infectious Diseases 2008;46:1746‐1750.

90. Pakyz A, Powell JP, Harpe SE, Johnson C, Edmond M, Polk RE. Diversity of antimicrobial use in 42 hospitals in the United States. Pharmacotherapy 2008;28:906‐912.

91. Assanasen S, Edmond M, Bearman G. Impact of two different levels of performance feedback on compliance with infection control process measures in two intensive care units. American Journal of Infection Control (in press).

92. Edmond MB, Lyckholm LJ, Diekema DJ. Ethical implications of active surveillance cultures and contact precautions for controlling multidrug‐resistant organisms in the hospital setting. Public Health Ethics (in press).

93. Edmond MB, Ober JF, Bearman G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. American Journal of Infection Control (in press).

94. Stevens MP, Bearman G, Rosato A, Edmond MB. Community‐Acquired Methicillin Resistant Staphylococcus aureus (CA‐MRSA) in a Women’s Collegiate Basketball Team. Southern Medical Journal (in press).

95. Edmond MB. Controlling methicillin‐resistant Staphylococcus aureus: An effective, alternative approach. Clinical Microbiology Newsletter 2008 (in press).

96. Marra AR, D’Arco C, Bravim BdeA, Martino MDV, Correa L, Silva CV, Lamblet LCR, Junior MS, de Lima G, Guastelli LR, Barbosa L, dos Santos OFP, Edmond MB. A controlled trial of measurement and feedback of hand hygiene in step‐down units. Infection Control and Hospital Epidemiology (in press).

97. Stevens MP, Edmond MB. The rising tide: Skin and soft tissue infections due to community‐associated methicillin Staphylococcus aureus. Southern Medical Journal (in press).

98. Marra AR, de Almeida SM, Correa L, Silva M, Martino MDV, Cal RGR, Edmond MB, dos Santos OFP. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. (in press).

99. Edmond MB. Getting to zero: Is it safe? (Invited manuscript for Infection Control and Hospital Epidemiology, in press).

100. Jones DL, Munro CL, Grap MJ, Kitten T, Edmond M. Oral care and bacteremia risk in mechanically ventilated adults (under review).

101. Wenzel RP, Bearman G, Edmond MB. Screening for MRSA: A flawed infection control intervention (under review).


- 20 -

102. Verdream EA, Bearman G, Robles JR, Dong M, Edmond MB, Polk RE. Vancomycin use over 6 years at a university teaching hospital—the impact of introducing antibiotic stop orders on defined daily dose, days of therapy and number of doses/1000 patient days: an interrupted time series analysis (in preparation).

103. Heipel D, Reynolds L, Wharton C, Ober J, Bearman G, Edmond M. What is white and black and gray all over? CDC nosocomial infection definitions (in preparation).

104. Lyckholm L, Youseff J, Shickle L, Edmond MB. Predictors of missed appointments in an urban, academic oncology clinic (in preparation).

105. Markley JD, Edmond MB. Post‐malaria neurologic syndrome: Case report and review of the literature (in preparation).

106. Stevens MP, Edmond MB. Vancomycin‐resistant enterococcal meningitis: Case report and review of the literature (in preparation).

12.2 Abstracts 1. Edmond MB, Khakoo RA, McTaggart B, Solomon R. Effect of bedside needle disposal units

on needle recapping frequency and needlestick injury. American Society for Microbiology General Meeting, March 1987, Atlanta, Georgia.

2. Edmond MB, Khakoo RA, Mazella V. Pubic osteomyelitis: A diagnostic dilemma. Pennsylvania/West Virginia American College of Physicians Regional Meeting, November 1988, Philadelphia, Pennsylvania.

3. Edmond MB, Khakoo RA. Pulmonary complications of Rocky Mountain Spotted Fever. Pennsylvania/West Virginia American College of Physicians Regional Meeting, October 1989, Pittsburgh, Pennsylvania.

4. Edmond MB, Khakoo RA. Pulmonary cryptococcosis. West Virginia American College of Physicians State Meeting, January 1990, Charleston, West Virginia.

5. Sundberg R, Shapiro R, Darras F, Jensen C, Scantlebury V, Jordan M, McCauley J, Kusne S, Edmond MB, Ho M, Jereb J, Burwen D, Medvick J, Pasculle W, Hakala T, Simmons RL, Starzl TE. A tuberculosis outbreak in a renal transplant program. First International Congress on FK506, August 1991, Pittsburgh, Pennsylvania.

6. Fisher MA, Shen H, Rogers A, Billie M, Edmond M, Tarry W. Fluconazole therapy of hepatosplenic candidiasis in neutropenic rabbits. American Society for Microbiology General Meeting, April 1992, New Orleans, Louisiana.

7. Edmond M, Hollis R, Houston R, Wenzel R. Active role for hospital epidemiology in an outbreak of meningococcal disease. Society for Hospital Epidemiology of America Meeting, April 1993, Chicago, Illinois.

8. Edmond M, Wenzel R, Yank T, Doebbeling B. The effect of influenza vaccination on sick leave among hospital employees. Society for Hospital Epidemiology of America Meeting, April 1993, Chicago, Illinois.

9. Edmond MB, Hollis RJ, Houston AK, Wenzel RP. Epidemiologic analysis of an outbreak of meningococcal disease. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1993, New Orleans, Louisiana.

10. Edmond MB, Clark TG, Doebbeling BN. Independent risk factors for multiple percutaneous injuries. Meeting of the Midwest Section of the American Federation for Clinical Research, November 1993, Chicago, Illinois. Clinical Research 1993;41:646A.

11. Edmond MB, Zeitler RR, Woodin JR, Wenzel RP, Doebbeling BN. Predictors of influenza vaccine acceptance in health care workers. Society for Hospital Epidemiology of America


- 21 -

Meeting, March 1994, New Orleans, Louisiana. 12. Edmond MB, Clark TG, Askelson DL, Doebbeling BN. Determinants of recurrent

percutaneous injuries reported by health care workers. Society for Hospital Epidemiology of America Meeting, March 1994, New Orleans, Louisiana.

13. Edmond MB, Ober JF, Weinbaum DL, Sanford MD, Pfaller MA, Hwang T, Wenzel RP. Risk factors for vancomycin‐resistant enterococcal bacteremia. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1994, Orlando, Florida.

14. Edmond MB, Adams JR Jr, Trilla A, RP Wenzel, Doebbeling BN. Socioeconomic status as a risk factor for nosocomial infection and mortality. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1994, Orlando, Florida.

15. Wiblin RT, Edmond MB, Rhomberg PR, Pfaller MA, Herwaldt LA, Wenzel RP. Introduction of vancomycin‐resistant Enterococcus faecium and institutional response for infection control. Infectious Diseases Society of America Meeting, October 1994, Orlando, Florida.

16. Edmond MB, Jones RN, Pfaller MA, Wallace SE, Wenzel RP. Control of vancomycin‐resistant enterococci in US hospitals. Infectious Diseases Society of America Meeting, September 1995, San Francisco, California.

17. Edmond MB, Ober JF, Weinbaum DL, Wenzel RP. Natural history and attributable morbidity and mortality of vancomycin‐resistant enterococcal bacteremia. Society for Hospital Epidemiology of America Meeting, April 1996, Washington, DC.

18. Edmond MB, Jones RN, Pfaller MA, Wallace SE, Wenzel RP. Multicenter surveillance for nosocomial enterococcal bacteremia: A comparison of vancomycin‐sensitive vs. vancomycin‐resistant cases. Society for Hospital Epidemiology of America Meeting, April 1996, Washington, DC.

19. Wright WL, Reynolds TM, Wells VD, Edmond MB. The impact of vancomycin restriction on infections due to vancomycin‐resistant enterococci. Society for Hospital Epidemiology of America Meeting, April 1996, Washington, DC.

20. Pfaller MA, Jones RN, Messer S, Houston A, Hollis RJ, Edmond M, Wenzel RP and the SCOPE Study Group. Strain variation and antifungal susceptibility among nosocomial bloodstream isolates of Candida spp from US hospitals participating in the SCOPE survey. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1996, New Orleans, Louisiana.

21. Jones RN, Pfaller MA, Marshall S, Erwin M, Edmond M, Wenzel R. Nosocomial enterococcal bloodstream infections in the SCOPE Survey: Drug resistance, species occurrence and identification accuracy. Infectious Diseases Society of America Meeting, September 1996, New Orleans, Louisiana.

22. Edmond MB, Wallace SE, Pfaller MA, Jones RN, Wenzel RP. Surveillance at 49 U.S. medical centers for vancomycin‐resistant enterococcal (VRE) bacteremia. Infectious Diseases Society of America Meeting, September 1996, New Orleans, Louisiana.

23. Wong MT, Edmond MB, DeWitt C. Toxic shock syndrome associated with severe Group B streptococcal infections. Infectious Diseases Society of America Meeting, September 1996, New Orleans, Louisiana.

24. Bischoff W, Emery CL, Hall G, Wenzel RP, Edmond MB. Is Dial® Soap effective against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococci? Society for Healthcare Epidemiology of America Meeting, April 1997, St. Louis, MO.

25. Bischoff W, Hall G, Wenzel RP, Edmond MB. An outbreak of methicillin resistant Staphylococcus aureus infections in a tertiary care hospital: Role of transfers from a prison.


- 22 -

Society for Healthcare Epidemiology of America Meeting, April 1997, St. Louis, MO. 26. Gorchs AC, Edmond MB. Sharing call‐rooms with the opposite sex: Housestaff Opinions.

Association of Program Directors in Internal Medicine Meeting, March 1997, Philadelphia, PA.

27. Franchi D, Bischoff WE, Kilpatrick J, Wenzel RP, Edmond MB. Dating multiple dose vials: An analysis of location and content. Society for Healthcare Epidemiology of America Meeting, April 1997, St. Louis, MO.

28. Wong AHM, Wenzel RP, Edmond MB. Vancomycin‐resistant enterococcal urinary tract infections. Society for Healthcare Epidemiology of America Meeting, April 1997, St. Louis, MO.

29. Edmond MB, Jones RN, Pfaller MA, McClish DK, Campbell L, Wenzel RP. Nosocomial bloodstream infections: A one‐year analysis at 50 US medical centers. Infectious Diseases Society of America Meeting, September 1997, San Francisco, CA.

30. Franchi D, Bischoff WE, Wenzel RP, Edmond MB. Multiple dose vial policies: A survey of US hospitals. Infectious Diseases Society of America Meeting, September 1997, San Francisco, CA.

31. Franchi D, Wong AHM, Hall G, Edmond MB, Wenzel RP. Surveillance for vancomycin‐resistant Staphylococcus aureus in a high‐risk population. Infectious Diseases Society of America Meeting, September 1997, San Francisco, CA.

32. Bischoff WE, Wong MT, Hall G, Edmond MB. Occurrence of vancomycin resistant Enterococcus faecium strains in clinical isolates. Infectious Diseases Society of America Meeting, September 1997, San Francisco, CA.

33. Bischoff WE, Franchi D, Wenzel RP, Edmond MB. Use of multidose vials in a tertiary care center: Cost analysis of 30‐day expiration policy versus manufacturer’s expiration date. Infectious Diseases Society of America Meeting, September 1997, San Francisco, CA.

34. Edmond MB, Wallace SE, Pfaller MA, Jones RN, Wenzel RP. Epidemiology of gram‐positive nosocomial infections in US hospitals. International Congress on Macrolides, Azalides, Streptogramins, and Ketolides, January 1998, Barcelona, Spain.

35. Reynolds L, Ober J, Wong M, Savage L, Oliveira T, Embry R, Edmond M. The importance of appropriate antimicrobial prophylaxis for coronary artery bypass grafting. Association of Professionals in Infection Control Meeting, May 1998, San Diego, CA.

36. Kadic C, Meier P, Lyckholm L, Edmond M. Autologous blood donation and the potential for bloodborne pathogen exposure. Association of Professionals in Infection Control Meeting, May 1998, San Diego, CA.

37. Bischoff WE, Reynolds TM, Hall GO, Wenzel RP. Molecular epidemiology of vancomycin‐resistant Enterococcus faecium strains in a large urban hospital over a 5‐year period. Society for Healthcare Epidemiology of America Meeting, April 1998, Orlando, FL.

38. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by healthcare workers: The impact of an education and patient awareness program. Society for Healthcare Epidemiology of America Meeting, April 1998, Orlando, FL.

39. Edmond M, Roberson M, Hasan N. The dishonest dean’s letter: An analysis of 532 dean’s letters from 99 US medical schools. Association of Program Directors in Internal Medicine Meeting, April 1998, San Diego, CA.

40. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by healthcare workers: The impact of an education and patient awareness program and the introduction of a new hand disinfectant. Interscience Conference on Antimicrobial Agents


- 23 -

and Chemotherapy, September 1998, San Diego, CA. 41. Wisplinghoff H, Seifert H, Edmond M. Serratia marcescens bacteremia: Epidemiology,

clinical features, and outcomes. Infectious Diseases Society of America Meeting, November 1998, Denver, CO.

42. Wisplinghoff H, Seifert H, Edmond M. Epidemiology of bacteremia in hematology/oncology patients in U.S. hospitals. Infectious Diseases Society of America Meeting, November 1998, Denver, CO.

43. Reynolds L, Ober J, Wong M, Savage L, Oliveira T, Embrey R, Edmond M. The importance of appropriate antimicrobial prophylaxis for coronary artery bypass grafting. National Nosocomial Infections Surveillance System Conference, October 1998, Atlanta, GA.

44. Cox G, Edmond M. Does marital status effect how medical students choose an internal medicine program? Association of Program Directors in Internal Medicine Meeting, April 1999, New Orleans, LA.

45. Wisplinghoff H, Seifert H, Edmond M. Nosocomial bloodstream infections in pediatric patients in US hospitals: Epidemiology, clinical features and resistance patterns. Society for Healthcare Epidemiology of America Meeting, April 1999, San Francisco, CA.

46. Wisplinghoff H, Seifert H, Edmond M. Nosocomial bloodstream infections due to Serratia marcescens in US hospitals: Epidemiology, clinical features and susceptibilities. Society for Healthcare Epidemiology of America Meeting, April 1999, San Francisco, CA.

47. Ober J, Wong M, Hodson M, Reynolds L, Franchi D, Hall G, Richard M, Edmond M. A multifaceted approach to control endemic vancomycin‐resistant enterococci in critical care units. Association of Professionals in Infection Control Meeting, May 1999, Washington, DC.

48. Ober J, Wong M, Hodson M, Reynolds L, Richard M, Edmond M. Infection control nurse liaison: Our link to the 1990s expanding “hospital” environment. Association of Professionals in Infection Control Meeting, May 1999, Washington, DC.

49. Reynolds L, Ober J, Craven H, Richard M, Wong M, Edmond M. Meeting the challenge: Providing a high‐quality annual mass education event. Association of Professionals in Infection Control Meeting, May 1999, Washington, DC.

50. Ober J, Wong M, Richard M, Hodson M, Reynolds L, Edmond M. Infection control drills: Are they needed? Association of Professionals in Infection Control Meeting, May 1999, Washington, DC.

51. Wisplinghoff H, Coimbra M, Wenzel R, Edmond M. Systemic inflammatory response (SIRS) in adult patients with hospital‐acquired bacteremia due to S. aureus. American Society for Microbiology Meeting, May 1999, Chicago, IL.

52. Wisplinghoff H, Seifert H, Edmond M. Nosocomial bloodstream infections due to Serratia marcescens in US hospitals: Epidemiology, clinical features and susceptibilities. Society for Healthcare Epidemiology of America Meeting, April 1999, San Francisco, CA.

53. Wisplinghoff H, Seifert H, Edmond M, Wenzel R. Nosocomial bloodstream infections due to Acinetobacter spp in US hospitals: Molecular epidemiology, clinical features and susceptibilities. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1999, San Francisco, CA.

54. Coimbra M, Hall G, Tallent S, Wisplinghoff H, Wallace S, Edmond M, Figueiredo A, Wenzel R. Clonal Spread of MRSA over a wide geographic area in the US. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1999, San Francisco, CA.

55. Franchi D, Ober J, Hodson M, Hall G, Tallent S, Edmond M. Outbreak of vancomycin‐resistant Enterococcus faecium (VREF) in a tertiary care center burn unit. Infectious


- 24 -

Diseases Society of America Meeting, November 1999, Philadelphia, PA. 56. Tallent SM, Wenzel RP, Edmond MB. Outbreak of Staphylococcus aureus infections in a

correctional facility. 4th Decennial International Conference on Nosocomial and Healthcare‐Associated Infections, March 2000, Atlanta, GA.

57. Ober JF, Hall G, Hodson M, Blythe C, Reynolds L, Edmond MB. Hurricane‐induced fungal contamination of the hospital environment. 4th Decennial International Conference on Nosocomial and Healthcare‐Associated Infections, March 2000, Atlanta, GA.

58. Edmond M, Deschenes J, Eckler M, Wenzel R. Racial bias in using USMLE scores for granting internal medicine residency interviews. Association of Program Directors in Internal Medicine Meeting, October 2000, Washington, DC.

59. Tallent SM, Bischoff T, Ostrowsky B, Wenzel RP, Edmond MB. Vancomycin susceptibility of methicillin‐resistant S. aureus (MRSA) isolates causing nosocomial bloodstream infections. Society for Healthcare Epidemiology of America Meeting, April 2001, Toronto, Canada.

60. Ober J, Edmond M, Ostrowsky B. The case of the cold thermometers. Society for Healthcare Epidemiology of America Meeting, April 2001, Toronto, Canada.

61. Blythe C, Ober J, Ostrowsky B, Edmond M. An outbreak of post‐circumcision dermatitis in a newborn nursery. Association of Professionals in Infection Control Meeting, June 2001, Seattle, WA.

62. Hodson M, Ober J, Hall G, Tallent S, Ostrowsky B, Yelon J, Edmond M. An Outbreak of methicillin‐resistant Staphylococcus aureus and multidrug‐resistant Pseudomonas aeruginosa in a burn intensive care unit. Association of Professionals in Infection Control Meeting, June 2001, Seattle, WA.

63. Edmond MB, McClish D, Massie T, Wiblin RT, Kauffman C, Welage L, Goff LA, Rex JH, Schuster M, Wenzel RP. Risk factors for nosocomial candidemia among patients in eight surgical intensive care units. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001, Chicago, IL.

64. Borer A, Ostrowsky B, Edmond M, Bischoff T, McClish D, Wenzel R. Epidemiology and risk factors for nosocomial Pseudomonas aeruginosa bacteremia in U.S. Hospitals, 1995‐2000. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001, Chicago, IL.

65. Borer A, Ostrowsky B, Espinel‐Ingroff A, Hall G, Edmond M, Wenzel R. In‐vitro activity of handwashing agents against Candida albicans. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001, Chicago, IL.

66. Coudron PE, Young E, Tallent SM, Moland ES, Hanson ND, Edmond MB, Wenzel RP. Occurrence of extended‐spectrum and AmpC β‐lactamases (BLs) in US bacteremic isolates of K. pneumoniae: Finding of two isolates that harbored inducible plasmid‐mediated ACT‐1‐like BLs. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001, Chicago, IL.

67. Polk R, Johnson C, McClish D, Edmond M, Wenzel R. Trends in prescribing in 35 US hospitals and resistance for P. aeruginosa: A SCOPE‐MMIT Report. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001, Chicago, IL.

68. Ostrowsky B, Ober J, Reynolds L, Hodson M, Edmond M. Infection control practices in burn units. Society for Healthcare Epidemiology of America Meeting, April 2002, Salt Lake City, UT.

69. Polk R, Johnson C, Qaqish R, McClish D, Edmond M, Wenzel R. Sources of Variability in Hospital Antibiotic Use. Society for Healthcare Epidemiology of America Meeting, April


- 25 -

2002, Salt Lake City, UT. 70. Polk R, Johnson C, Qaqish R, McClish D, Edmond M, Wenzel R. Relationship of ciprofloxacin‐

resistant P. aeruginosa (CRPa) and quinolone (FQ) exposure, measured by DDD/1000PD and grams/1000PD, in U.S. hospitals. Society for Healthcare Epidemiology of America Meeting, April 2002, Salt Lake City, UT.

71. Reynolds L, Ober J, Hall G, Ostrowsky B, Edmond M. Methicillin‐resistant Staphylococcus aureus in a neonatal intensive care unit linked to a previous outbreak. Association of Professionals in Infection Control Meeting, May 2002, Nashville, TN.

72. Baum HV, Ober JF, Wenzel RP, Edmond MB. Risk factors for nosocomial bloodstream infections in a high‐risk population. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2002, San Diego, CA.

73. Johnson CK, Polk R, Edmond M, Wenzel RP. Trends in antimicrobial use (AU) from 1999 to 2001 in 36 U.S. hospitals: A SCOPE‐MMIT report. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2002, San Diego, CA.

74. Polk RE, Nichols M, Johnson CK, Edmond M, Wenzel R. Hospitals with “closed” antibiotic formularies are associated with higher rates of bacterial resistance: From the SCOPE‐MMIT Antimicrobial Surveillance Network. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2002, San Diego, CA.

75. Tallent SM, Christie GE, Edmond MB, Wenzel RP. Characterization of linezolid resistance in an Enterococcus faecium isolate from a nosocomial bloodstream infection. American Society for Microbiology Meeting, May 2003, Washington, DC.

76. Wisplinghoff H, Bischoff T, Tallent S, Wenzel RP, Edmond MB. Current trends in nosocomial bloodstream infections in United States hospitals: Prospective analysis of 27,000 cases from a nationwide surveillance study. Society for Healthcare Epidemiology of America Meeting, April 2003, Arlington, VA.

77. Reynolds L, Ostrowsky B, Cone S, Rozycki H, Edmond M. Interventional epidemiology: A multidisciplinary teaching approach to reduce bloodstream infections in neonates. Association of Professionals in Infection Control Meeting, June 2003, San Antonio, TX.

78. Wisplinghoff H, Bischoff T, Seifert H, Wenzel RP, Edmond MB. Systemic inflammatory response in patients with nosocomial bloodstream infections due to Candida species. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 2003, Chicago, IL.

79. Bischoff T, Tallent S, Adera T, Wenzel RP, Edmond MB. Epidemiology of nosocomial candidemia: A six‐year national perspective. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 2003, Chicago, IL.

80. Edmond MB, Ober JF, Hall GO, Parkhill D, Smith R, Bearman GML, Wenzel RP. Prevalence of inpatients at risk for complications of nosocomial vaccinia. Society for Healthcare Epidemiology Meeting, April 2004, Philadelphia, PA.

81. Bearman GML, Rosato A, Tallent SM, Edmond MB. Susceptibility of coagulase‐negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine impregnated central venous catheter. Society for Healthcare Epidemiology Meeting, April 2004, Philadelphia, PA.

82. Berhe M, Edmond MB, Wenzel RP, Bearman GML. An assessment of healthcare worker attitudes regarding nosocomial infections. Society for Healthcare Epidemiology Meeting, April 2004, Philadelphia, PA.

83. Reynolds L, Mickell J, Bearman G, Edmond M. A hand hygiene campaign to prevent the


- 26 -

transmission of respiratory syncytial virus in the pediatric intensive case unit. Association of Professionals in Infection Control Meeting, June 2004, Phoenix, AZ.

84. Smith R, Ober J, Parkhill D, Bearman G, Edmond M. Pseudo‐outbreak of ventriculitis in a neurosurgical ICU. Association of Professionals in Infection Control Meeting, June 2004, Phoenix, AZ.

85. Ober J, Allen B, Atkinson L, Alvis D, Boyle P, Bratcher C, Bryson K, Daniel J, Hannum D, Parkhill D, Reardon L, Reynolds L, Smith R, Bearman G, Edmond M. Hurricane Isabel brought communication to a standstill but it will not happen again, the code system is here! Association of Professionals in Infection Control Meeting, June 2004, Phoenix, AZ.

86. Bearman GML, Tortorella F, Allen P, Edmond MB. Impact of rapid HIV testing on healthcare worker HIV post‐exposure prophylaxis: a cost benefit analysis. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 2004, Washington, DC.

87. Bar K, Wisplinghoff H, Wenzel RP, Bearman GML, Edmond MB. Systemic inflammatory response associated with nosocomial enterococcal bloodstream infection. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 2004, Washington, DC.

88. R Polk, Johnson CK, Edmond M. Diversity in hospital antibacterial use and bacterial resistance. Interscience Conference on Antimicrobial Agents and Chemotherapy, October 2004, Washington, DC.

89. Sessler CN, Perry J, Sampson R, Edmond M. CD‐ROM‐based program for medical student and housestaff education regarding central venous catheter procedure and prevention of complications. Society for Critical Care Meeting, January 2005.

90. Forbes BA, Bollinger S, Edmond MB, Bearman GML, Major Y. Improved detection of vancomycin‐resistant enterococci (VRE) from rectal swabs using the swab extraction tube system (SETS; Roche Diagnostics). American Society for Microbiology Meeting, June 2005, Atlanta, GA.

91. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Longitudinal analysis of the relationship between fluoroquinolone use and resistance in Pseudomonas aeruginosa and Staphylococcus aureus in 24 US hospitals, 1999‐2003. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

92. Marra AR, Pereira CAP, Wey SB, Gales AC, Cal RGR, Menezes LC, Bearman G, Wenzel RP, Edmond MB. Epidemiology and microbiological characteristics of bloodstream infections due to metallo‐β‐lactamase‐producing Pseudomonas aeruginosa. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

93. Edmond MB White‐Russell MB, Woolard CD, Ober JF, Bearman GML. Statewide survey of human resources for nosocomial infection surveillance. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

94. Edmond MB White‐Russell MB, Woolard CD, Ober JF, Bearman GML. Surveillance methodologies for nosocomial infections in Virginia hospitals: Results of a statewide survey. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

95. Marra AR, Bar K, Bearman G, Wenzel RP, Edmond MB. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

96. Marra AR, Bearman G, Wenzel RP, Edmond MB. Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

97. Marra AR, Bearman G, Wenzel RP, Edmond MB. Evaluation of the Charlson weighted


- 27 -

comorbidity index and MacCabe classification as predictors of mortality in patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

98. Berhe M, Edmond MB, Bearman G. Measurement and feedback of infection control process measures in the intensive care unit: impact on compliance. Society for Healthcare Epidemiology Meeting, April 2005, Los Angeles, CA.

99. Heipel D, Ober J, Edmond M, Bearman G. Surgical site infection surveillance for neurosurgical procedures: A comparison of passive surveillance by surgeons to active surveillance by infection control professionals. Association of Professionals in Infection Control Meeting, June 2005, Baltimore, MD.

100. Reynolds L, Liverman T, Jacobs D, Bearman G, Edmond M. A creative yet simple approach to improve hand hygiene compliance in the pediatric intensive care unit. Association of Professionals in Infection Control Meeting, June 2005, Baltimore, MD.

101. Ober JF, Edmond M. Applying epidemiologic principles to mandatory reporting. Association of Professionals in Infection Control Meeting, June 2005, Baltimore, MD.

102. Lyckholm LJ, Kreutzer KO, Smith TJ, Edmond MB. Developing innovative strategies to meet ACGME requirements and promote learning in a hematology/oncology fellowship program. Journal of Clinical Oncology 2005;23:558S‐558S.

103. Marra AR, Bearman G, Wenzel RP, Edmond MB. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2005, Washington, DC.

104. Opilla MT, Wolff‐Small T, Marra AR, Kirby DF, Edmond MB. Use of ethanol lock therapy to prevent catheter related bloodstream infection in frequently infected home total parenteral nutrition patients. American Society of Parenteral and Enteral Nutrition, February 2006, Dallas, TX.

105. Bearman G, Marra A, Sessler C, Smith W, Wenzel R, Kockler D, Edmond M. A controlled trial of universal gloving vs. contact precautions for preventing the transmission of multidrug‐resistant pathogens. Society for Healthcare Epidemiology of America Meeting, March 2006, Chicago, IL.

106. Bearman G, Marra A, Sessler C, Smith W, Wenzel R, Kockler D, Edmond M. Healthcare worker attitudes during a controlled trial of universal gloving for preventing the transmission of multidrug‐resistant pathogens. Society for Healthcare Epidemiology of America Meeting, March 2006, Chicago, IL.

107. Marra A, Edmond M, Bearman G. Hospital‐acquired Clostridium difficile disease in intensive care unit: epidemiology, clinical course and outcome. International Society for Infectious Diseases Meeting, June 2006, Lisbon, Portugal.

108. Reynolds L, Liverman T, Thomas D, Mickell J, Bearman G, Edmond M. Closed is the word: Creating a closed urinary catheter system in a pediatric intensive care unit. Association of Professionals in Infection Control Meeting, June 2006, Tampa, FL.

109. Heipel D, Ober J, Adams C, Bearman G, Edmond M. The importance of leadership in effecting change: A tale of 2 ICUs. Association of Professionals in Infection Control Meeting, June 2006, Tampa, FL.

110. Rudnick E, Edmond M, Heller AJ, Lyckholm LJ. Differences among housestaff in familiarity and comfort with a unilateral DNR policy. Association of American Medical Colleges Annual Meeting, October 2006, Seattle, WA.


- 28 -

111. Siepler JK, Opilla M, Diamanditis T, Hester M, Nishakawa R, Okamoto R, Edmond M, Kirby D. Reduction of catheter‐related bloodstream infections using ethanol locks in patients receiving home parenteral nutrition. European Society of Parenteral and Enteral Nutrition, October 2006, Istanbul, Turkey.

112. Stevens MP, Edmond MB, Heipel D, Major Y, Rosato A, Bearman G. Community‐acquired methicillin‐resistant Staphylococcus aureus in a women’s collegiate basketball team. Society for Healthcare Epidemiology of America Meeting, April 2007, Baltimore, MD.

113. Assanasen S, Edmond MB, Bearman G. Impact of two different levels of performance feedback on compliance with infection control process measures in two intensive care units. Society for Healthcare Epidemiology of America Meeting, April 2007, Baltimore, MD.

114. Ober JF, Steigleder D, Tortorella FJ, Bearman, G, Edmond MB. Assessing noncompliance with influenza vaccination in healthcare workers. Society for Healthcare Epidemiology of America Meeting, April 2007, Baltimore, MD.

115. Edmond MB, Ober JF, Bearman G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. Society for Healthcare Epidemiology of America Meeting, April 2007, Baltimore, MD.

116. Stevens MP, Sampson R, Edmond MB. The effectiveness of ICU triage for inpatient medical services in an urban teaching hospital. Virginians Improving Patient Care and Safety Meeting, May 2007, Richmond, VA.

117. Edmond MB, Ober JF, Winfield S, Sessler C, Bearman G. Implementation of simple, low‐cost interventions to reduce nosocomial infections in the critical care setting. Virginians Improving Patient Care and Safety Meeting, May 2007, Richmond, VA.

118. Heipel D, Reynolds L, Wharton C, Ober J, Bearman G, Edmond M. What is white and black and gray all over? CDC nosocomial infection definitions. Association of Professionals in Infection Control Meeting, June 2007, San Jose, CA.

119. Paulus T, Wisplinghoff H, Stefanik D, Edmond MB, Seifert H. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 217 epidemiologically defined Acinetobacter bloodstream isolates. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2007, Chicago, IL.

120. Stevens MP, Reynolds L, Major Y, Rosato A, Bearman G, Edmond MB. Sequential community‐associated methicillin resistant Staphylococcus aureus (CA‐MRSA) outbreaks in a neonatal intensive care unit. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

121. Assanasen S, Haner CV, Kleiner EA, Rosato AE, Edmond MB, Bearman GM. Nasal carriage of community‐associated methicillin‐resistant Staphylococcus aureus among university students and an ambulatory patient population. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

122. Assanasen S, Haner CV, Kleiner EA, Rosato AE, Edmond MB, Bearman GM. Oxacillin‐susceptible mecA‐positive S. aureus nasal carriage in adults. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

123. Verdream E, Bearman G, Polk RE, Edmond MB, Robles JR. Vancomycin (V) use at a university hospital‐the impact of introducing an antibiotic stop order on defined daily dose‐, days of therapy‐ and number of doses1000 patient days. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

124. Edmond MB, Ober JF, Duane TM, Sessler CN, Bearman G. Continued reduction device‐related MRSA infections in the critical care setting without the use of active surveillance


- 29 -

cultures. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL. 125. Markley JD, Stevens MP, Haner CV, Rosato A, Edmond MB, Bearman G. Is MRSA hiding in

the gym? Lack of MRSA detection in a university fitness center. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

126. Ober JF, Adcock LH, Bailey KM, Giannetta ET, Edmond MB. Preparing infection control professionals for mandatory reporting of hospital acquired infections is necessary for improving surveillance validity. Society for Healthcare Epidemiology of America Meeting, April 2008, Orlando, FL.

127. Jones DJ, Munro CL, Grap MJ, Kitten T, Edmond M. Risks of bacteremia in the ICU: Does oral care matter? National Teaching Institute and Critical Care Exposition, May 2008, Chicago, IL.

128. Wisplinghoff H, Bar K, Seifert H, Marra AR, Bearman G, Wenzel RP, Edmond MB. Comparison of Systemic Inflammatory Response in Patients with Nosocomial Bloodstream Infections due to S. aureus, P. aeruginosa, Enterococcus species and Candida species. International Society for Infectious Diseases, June 2008, Kuala Lumpur.

129. Ebbers J, Geurtz L, Wisplinghoff H, Stefanik D, Edmond M, Seifert H. Comparison of CLSI broth microdilution and VITEK AST‐YS01 cards for antifungal susceptibility testing of Candida bloodstream isolates recovered from the SCOPE Project. Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2008, Washington, DC (submitted).

12.3 Books and/or Chapters 1. Edmond MB, Wenzel RP. Isolation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and

Practice of Infectious Diseases. 4th edition. New York: Churchill Livingstone, 1995:2575‐2579. 2. Edmond MB, Wenzel RP. Infection control. In: Mandell GL, Bennett JE, Dolin R, eds. Principles

and Practice of Infectious Diseases. 4th edition. New York: Churchill Livingstone, 1995:2572‐2575.

3. Edmond MB, Nettleman MD. Lyme Disease. In: Bia FJ, ed. Travel Medicine Advisor. Chicago: American Health Consultants, 1995:35.1‐35.19.

4. Manual of Infection Control in the Hospital. Wenzel R, Edmond M, Pittet D, Devaster J‐M, Brewer T, Geddes A, Butzler J‐P, eds. Hamilton: B.C. Decker, Inc 1998.

5. Edmond MB. Isolation. In: Herwaldt LA, ed. A Practical Handbook for Hospital Epidemiologists. Thorofare, NJ: Society for Healthcare Epidemiology of America, 1998;179‐187. Also published in Infection Control and Hospital Epidemiology 1997;18:58‐64.

6. Edmond MB. Enterococcal species. In: International Infection Control. Wenzel R, Edmond M, Pittet D, Devaster J‐M, Geddes A, Butzler J‐P, eds. Hamilton: BC Decker, 1998;132‐135.

7. Bischoff WE, Edmond MB. Staphylococcus aureus. In: International Infection Control. Wenzel R, Edmond M, Pittet D, Devaster J‐M, Geddes A, Butzler J‐P, eds. Hamilton: BC Decker, 1998;128‐131.

8. Edmond MB. Antimicrobial resistance and other epidemiologic considerations in the intensive care unit. In: Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC, eds. Textbook of Critical Care, 4th ed. Philadelphia: W.B. Saunders, 1999;780‐787.

9. Edmond MB, Wenzel RP. Isolation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edition. New York: Churchill Livingstone, 1999:2991‐2995.

10. Edmond MB, Wenzel RP. Organization for infection control. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edition. New York: Churchill Livingstone, 1999:2988‐2991.


- 30 -

11. Edmond MB. National and international surveillance systems for nosocomial infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections, 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2003:109‐119.

12. Wenzel RP, Edmond MB. Recognizing and managing biological terror. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections, 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2003:87‐100.

13. Bearman GML, Edmond MB. Isolation. In: Practical Handbook for Hospital Epidemiologists, 2nd ed. Thorofare, NJ: Society for Healthcare Epidemiology of America, 2004:143‐150.

14. Edmond MB, Wenzel RP. Isolation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th edition. New York: Churchill Livingstone, 2004:3326‐3330.

15. Edmond MB, Wenzel RP. Organization for infection control. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th edition. New York: Churchill Livingstone, 2004:3323‐3326.

16. Edmond M. Enterococci. In: Guide to Infection Control, 3rd ed. International Society of Infectious Diseases, 2004:213‐217.

17. Bearman GML, Edmond M. Staphylococcus aureus. In: Guide to Infection Control, 3rd ed. International Society of Infectious Diseases, 2004:218‐222.

18. Stevens MP, Edmond MB. Trichinellosis. In: Wallace R, ed. Public Health and Preventive Medicine, 15th ed. McGraw Hill, 2008:443‐445.

19. Edmond MB. Public reporting of nosocomial infection rates. In: Jarvis WR, ed. Hospital Infections, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:801‐811.

20. Stevens MP, Edmond MB. Enterococci. In: Guide to Infection Control, 4th ed. International Society of Infectious Diseases, 2008 (in press).

21. Stevens MP, Edmond MB. Staphylococcus aureus. In: Guide to Infection Control, 4th ed. International Society of Infectious Diseases, 2008 (in press).

22. Edmond MB, Wenzel RP. Isolation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th edition. New York: Churchill Livingstone (in preparation).

23. Edmond MB, Wenzel RP. Organization for infection control. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th edition. New York: Churchill Livingstone (in preparation).

12.4 Other ‐ Software 1. Herwaldt LA, Edmond MB, Instructional Software Development Group. Outbreak II: An

Epidemiologic Investigation. University of Iowa, 1997.

12.5 Other ‐ Media Newspaper columns (invited) 1. November 27, 2005 Richmond Times‐Dispatch, Unlike bird flu’s possible threat, general version afflicts millions

Print Interviews 1. February 2, 1996 Boston Globe, Vancomycin‐resistant enterococci 2. July 15, 1996 Annals of Internal Medicine, Contaminated stethoscopes 3. April 1997 Medical Herald, Antibiotic‐resistant bacteria 4. May 29, 1997 Dallas Morning News, Antibiotic‐resistant staphylococci 5. May 29, 1997 Richmond Times‐Dispatch, Antibiotic‐resistant staphylococci


- 31 -

6. June 1997 Hospital Infection Control, Antibiotic‐resistant staphylococci 7. August 1997 Environmental Health Perspectives, Antibiotic‐resistant staphylococci 8. November 24, 1997 Philadelphia Inquirer, Antibiotic‐resistant staphylococci 9. May 15‐31, 1998 Internal Medicine World Report, Vancomycin‐resistant enterococci 10. August 1998 Infectious Diseases News, Isolation Precautions 11. October 1998 AAMC Reporter, Approaches to antibiotic resistance 12. August 19, 1999 Richmond Times‐Dispatch, Regulated medical waste 13. September 9, 1999 Richmond Times‐Dispatch, Antibiotic‐resistant staphylococci 14. January 2000 Gastroenterology & Endoscopy News, Vancomycin‐resistant enterococci 15. December 10, 2002 Richmond Times‐Dispatch, Smallpox vaccination 16. December 14, 2002 Richmond Times‐Dispatch, Smallpox vaccination 17. January 18, 2003 Denver Post, Smallpox vaccination 18. January 21, 2003 USA Today, Smallpox vaccination 19. February 13, 2003 Richmond Times‐Dispatch, Safety of smallpox vaccination 20. February 18, 2003 Washington Post, Smallpox vaccination 21. February 2003 AAMC Reporter, Smallpox vaccination 22. March 7, 2003 Richmond Times‐Dispatch, Influenza 23. March 29, 2003 Richmond Times‐Dispatch, Complications of smallpox vaccination 24. April 16, 2003 Richmond Times‐Dispatch, Severe Acute Respiratory Syndrome 25. May 11, 2003 Washington Post, Risks of smallpox vaccination 26. June 15, 2003 Internal Medicine News, Smallpox Vaccination 27. August 4, 2003 HealthDay.com, Infection control for SARS 28. October 22, 2003 Richmond Times‐Dispatch, Antibacterial household products 29. December 4, 2003 Richmond Times‐Dispatch, Influenza 30. December 11, 2003 Richmond Times‐Dispatch, Influenza epidemic 31. January 9, 2004 Hampton Roads Daily Press, Influenza 32. February 2004 Today’s Hospitalist, Catheter‐related bloodstream infections 33. June 2004 Hospital Infection Control, Mandatory reporting and disclosure of hospital

infection rates 34. September 29, 2004 Richmond Times‐Dispatch, Use of private hospital rooms to decrease infections 35. October 15, 2004 Richmond Times‐Dispatch, Influenza vaccine shortage 36. July 20, 2005 Newhouse News Service, Pandemic influenza 37. September 2, 2005 Newhouse News Service, Health effects of Hurricane Katrina 38. September 23, 2005 Richmond Times‐Dispatch, Contaminated cardioplegia solution 39. September 29, 2005 Fredericksburg Free Lance Star, Contaminated cardioplegia solution 40. November 2005 Medicine on the Net, Medical library remote access 41. September 16, 2006 Richmond Times‐Dispatch, E. coli outbreak associated with contaminated spinach 42. September 30, 2006 Richmond Times‐Dispatch, Transmission of common cold viruses via

contaminated surfaces 43. December 4, 2006 Richmond Times‐Dispatch, Hospital‐acquired infections 44. December 28, 2006 Baltimore Sun, Catheter‐associated bloodstream infections 45. December 28, 2006 United Press International, Catheter‐associated bloodstream infections 46. January 25, 2007 Richmond Times‐Dispatch, Norovirus outbreaks 47. February 28, 2007 Richmond Times‐Dispatch, Norovirus outbreak in the Richmond City Jail 48. May 31, 2007 Infection Control Today, Active surveillance for multidrug‐resistant organisms 49. August 1, 2007 Richmond Times‐Dispatch, Antibiotic‐resistant staphylococcal infections 50. September 18, 2007 Richmond Times‐Dispatch, Handwashing 51. October 17, 2007 Richmond Times‐Dispatch, MRSA infections 52. November 1, 2007 Richmond Times‐Dispatch, Controlling MRSA infections in the hospital 53. March 4, 2008 New York Times, Active surveillance for MRSA 54. April 8, 2008 Infection Control Today, Getting to Zero: Is it safe? Television Interviews 1. May 29, 1997 MSNBC (national), Antibiotic‐resistant staphylococci


- 32 -

2. November 2002 Richmond NBC 12, Infections associated with cruise ships (live, in studio) 3. December 2002 Richmond NBC 12, Smallpox vaccination (live, in studio) 4. December 19, 2002 On the Record with Greta van Sustern, FOX (national), Smallpox vaccination 5. December 20, 2002 Richmond Fox 6, Smallpox vaccination 6. January 2003 ARD (German National Television), Smallpox vaccination 7. January 24, 2003 Richmond NBC 12, Smallpox vaccination 8. February 2003 Richmond NBC 12, Tuberculosis 9. February 13, 2003 Richmond Fox 6, Tuberculosis 10. February 25, 2003 Richmond NBC 12, Influenza 11. March 17, 2003 Richmond NBC12, SARS (live, in studio) 12. March 19, 2003 Richmond NBC12, Paramyxovirus infections (live, in studio) 13. March 25, 2003 Richmond NBC‐12, Emerging infectious diseases (live, in studio) 14. March 25, 2003 Richmond NBC‐12, SARS (taped segment) 15. April 1, 2003 Richmond WRIC8, SARS (taped segment) 16. April 1, 2003 Richmond CBS 6, SARS (taped segment) 17. April 2, 2003 Richmond NBC12, SARS; smallpox vaccine complications (live, in studio) 18. April 9, 2003 Richmond NBC12, SARS: masks and quarantines (live, in studio) 19. April 16, 2003 Richmond NBC12, SARS (live, in studio) 20. April 16, 2003 Richmond CBS 6, SARS (taped segment) 21. April 28, 2003 Richmond NBC12, SARS (live, in studio) 22. May 2, 2003 Richmond NBC12, Smallpox vaccination (taped segment) 23. May 5, 2003 Richmond NBC12, Risks of smallpox vaccination (live, in studio) 24. May 23, 2003 Richmond NBC12, SARS and the link to animals (live, in studio) 25. June 9, 2003 Richmond NBC12, Monkeypox (live, in studio) 26. June 19, 2003 Richmond NBC12, Smallpox vaccination (live, in studio) 27. July 25, 2003 Richmond NBC12, West Nile Virus (live, in studio) 28. September 4, 2003 Richmond NBC12, Viral meningitis (live, in studio) 29. September 21, 2003 Richmond NBC12, Infections associated with contaminated water (live, in studio) 30. October 14, 2003 Richmond NBC12, Influenza vaccine (live, in studio) 31. October 23, 2003 Richmond NBC12, Impetigo (live, in studio) 32. October 23, 2003 Richmond NBC12, Impetigo (taped segment) 33. November 25, 2003 Richmond NBC12, Influenza nasal vaccine (taped segment) 34. November 26, 2003 Richmond NBC12, Influenza (live, in studio) 35. December 3, 2003 Richmond NBC12, Influenza (live, in studio) 36. December 3, 2003 Richmond CBS 6, Influenza (taped segment) 37. December 5, 2003 Richmond NBC12, Influenza vaccine (taped segment) 38. December 10, 2003 Richmond NBC12, Influenza nasal vaccine (taped segment) 39. December 11, 2003 Multistation Press Conference, Influenza epidemic 40. February 18, 2004 Richmond NBC12, Avian Influenza (live, in studio) 41. May 27, 2004 Richmond NBC12, Travelers Diarrhea (live, in studio) 42. June 2, 2004 Richmond NBC12, West Nile Encephalitis (live, in studio) 43. September 23, 2004 Richmond NBC12, Tuberculosis (live, in studio) 44. September 24, 2004 Richmond NBC12, Infections associated with body piercing (taped segment) 45. October 7, 2004 Richmond NBC12, Influenza vaccine shortage (taped segment) 46. October 10, 2004 Richmond ABC8, Adverse effects of influenza vaccination (taped segment) 47. February 10, 2006 Richmond NBC12, Meningitis (taped segment) 48. June 15, 2007 Richmond CBS 6, What is tuberculosis? (in studio taped segment) 49. August 1, 2007 Richmond ABC 8, Antibiotic‐resistant staphylococcal infections (taped segment) 50. August 15, 2007 Richmond CBS 6, Meningitis (live, in studio) 51. October 17, 2007 Richmond CBS 6, MRSA infections (taped segment) 52. October 18, 2007 Richmond ABC 8, MRSA infections (taped segment) 53. October 24, 2007 Richmond NBC 12, MRSA infections (live, in studio) 54. October 25, 2007 Multistation Press Conference, college student with meningitis 55. October 26, 2007 Richmond CBS 6, MRSA infections (in studio taped segment) 56. October 26, 2007 Richmond CBS 6, Meningitis (taped segment)

Michael B. Edmond, MD, MPH,medmond/Edmond _CV.pdfMichael B. Edmond, MD, MPH, MPA - 3 - •...

Documents

Transcript of Michael B. Edmond, MD, MPH,medmond/Edmond _CV.pdfMichael B. Edmond, MD, MPH, MPA - 3 - •...